MedTrace Logo

Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics

NCT06630273 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2026-03-27

No results posted yet for this study

Summary

The researchers doing this study are interested in doing the following:

* Biomarker research using fresh tumour tissue and normal blood cells, and if required, tumour tissue already collected.
* Bio-banking for use in future research using the collected tumour tissue / blood .

Conditions

  • Carcinoma

Sponsors & Collaborators

  • Canadian Cancer Trials Group

    lead NETWORK

Principal Investigators

  • Philippe Bedard · University Health Network, Princess Margaret Cancer Centre, Toronto, ON Canada

  • Anna Spreafico · University Health Network, Princess Margaret Cancer Centre, Toronto, ON Canada

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-04-30
Primary Completion
2027-12-31
Completion
2027-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06630273 on ClinicalTrials.gov